Purpose: We recently reported that the RBPj-dependent Notch signaling in chondrocytes modulates endochondral ossification and osteoarthritis (OA) development. Since this signal was shown to be mediated through induction of the target gene Hes1 in chondrocytes, the present study investigated the role of Hes1 and the underlying mechanism during OA development. Methods: We generated tissue-specific knockout mice of Hes1 by mating Sox9-Cre knock-in mice or tamoxifen-inducible Col2a1-Cre transgenic mice (Col2a1-Cre fl/fl mice, and created a surgically induced OA model by resecting the medial collateral ligament and the medial meniscus in the knee joints one week after the injection. The OA severity was quantified by the OARSI histopathology grade 8 weeks after the surgery. We examined transcriptional regulation by chromatin immunoprecipitation (ChIP) sequencing using human chondrogenic SW1353 cells transfected with the FLAG-tagged Hes1 construct, and confirmed the transactivation by luciferase assay using HeLa cells transfected with the reporter construct containing a promoter fragment of the marker genes. For expression analyses, we performed immunofluorescence and realtime RT-PCR. For protein-protein interaction analyses, we performed co-immunoprecipitation (Co-IP) assay in SW1353 cells. For functional analyses, we used lentiviral doxycycline-inducible expression vectors in mouse chondrogenic ATDC5 cells and examined the expression of target genes by real-time RT-PCR. Results: Although the Sox9-Cre;Hes1 fl/fl mice died in the perinatal period, the embryos exhibited normal sketetal growth. However, the OA development was prevented in the Col2a1-Cre ERT ;Hes1 fl/fl knee joints more than in the control Hes1 fl/fl joints. OARSI grading confirmed that conditional knockout of Hes1 caused significant resistance to cartilage degradation. Immunofluorescence revealed that Mmp13 and Adamts5 expressions were suppressed in the articular cartilage of Col2a1-Cre ERT mice. ChIP sequencing showed the highest binding of Hes1 in intron 4 of MMP13 and in intron 7 of ADAMTS5, and the luciferase assay confirmed that Hes1 stimulated the enhancer activities of these elements. Although Hes1 is generally known to be a transcriptional repressor, the present data suggest that Hes1 directly enhances Mmp13 and Adamts5 expressions. To reveal the molecular mechanism underlying transcriptional induction of these catabolic factors by Hes1, we focused on calcium/ calmodulin-dependent protein kinase II (CaMKII), which is the only factor known to change Hes1 from transcriptional repressor to transcriptional activator by phosphorylating it. Among subtypes of CaMKII, the d form was most highly expressed in mouse articular chondrocytes.
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Immunofluorescence of the mouse experimental model revealed that both Hes1 and active CaMKII were increased in articular cartilage during OA progression. Co-IP confirmed the binding of Hes1 and CaMKIId proteins. When both these proteins were lentivirally co-overexpressed in ATDC5 cells, Mmp13 and Adamts5 expressions were induced more highly than a single overexpression of each gene. Furthermore, a mutagenesis of Hes1 in the serine residue of CaMKII phosphorylation site caused a loss of its ability to induce Mmp13 and Adamts5. Conclusions: Hes1 modulates OA development through the transactivation of Mmp13 and Adamts5 through the phosphorylation by CaMKIId. Notch/Rbpj and Hes1 pathways in cooperation with CaMKIId may be possible therapeutic targets of OA. Purpose: Persistent pain after joint replacement is a considerable problem affecting between 7 and 20% of total knee replacement (TKR) patients and 2-8% of total hip replacement (THR) patients. The aim of the present study was to assess the factors that contribute to patient satisfaction and mobility post joint replacement. Methods: 735 knee and hip osteoarthritis patients were recruited from orthopaedic clinics 1 year post total joint replacement and a research nurse assessed their level of mobility, satisfaction with their surgery, medical history, pain intensity, PainDETECT questionnaire scores, quality of life and quality of sleep. Catastrophizing and illness behavior were also available for a subset of patients. Results: Among the 308 patients who had undergone THR, 98% were very satisfied of the outcome of their surgery, 94% reported a significant pain improvement and 83% an improvement in their ability to walk post THR, 3.9% had undergone a revision surgery. This compared to 75% satisfaction in the 383 post TKR cases, 3.1% of whom had a revision surgery, 85% reported a pain improvement and 72% an improvement in mobility. Among patients who had undergone both TKR and THR procedures satisfaction was 84%, 90% reported a substantial pain improvement even though the rate of revision surgery has much higher (13.6%)than among TKR only or THR only cases. The factors that contributed to lack of satisfaction post surgery in THR cases were the WOMAC pain score (OR¼.25 95% CI 1.05-1.48 per Likert scale unit p<0.012) younger age (OR¼0.92 95%CI 0.86-0.99 per year p<0.018) and presence of revision surgery (OR¼8.13 95%CI 1.4-46 p<0.018). Among post-TKR patients the strongest factors contributing to lack of satisfaction were the WOMAC pain score (OR¼1.15 95%CI 1.06-1.24 per Likert scale unit), poor sleep (OR¼1.25 95%CI 1.04-1.49 in a scale 0-10) and presence of possible neuropathic pain (as defined by the PainDETECT questionnaire) (OR¼1.90 95%CI 1.03-3.49). Among patients with both TKR and THR procedures the only significant factor contributing to satisfaction was the WOMAC stiffness score (OR¼3.39 95%CI 1.21-9.48 per Likert scale unit). An analysis in a subset of 163 post-TKR cases on which catastrophizing measures were available revealed that, although a high catastrophizing score is indeed associated with satisfaction, this association was entirely mediated by pain and dropped from the model after adjusting for WOMAC pain scores. Using a receiver operating characteristics (ROC) analysis we found that among TKR cases, age, sex and BMI provide no useful information on patient satisfaction (area under the curve(AUC)¼0.496). On the other hand the presence of possible neuropathic pain (NP) alone achieved an AUC¼0.643 [95%CI 0.58 -0.705] on patient satisfaction which reached AUC¼0.743 [ 95%CI 0.691 -0.795 ] when added to age, sex, BMI, WOMAC score and poor sleep quality (see Figure 1) . Conclusions: Our data confirm the strong difference in patient related outcomes for THR and TKR and highlight the importance of understanding the factors that contribute to neuropathic pain like symptoms and to pain in general post TKR.
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LIFETIME RISK OF TOTAL HIP AND KNEE REPLACEMENT AND TEMPORAL TRENDS IN INCIDENCE BY HEALTH CARE SETTING, SOCIOECONOMIC STATUS AND GEOGRAPHIC LOCATION
M. Bohensky y, I. Ackerman y, R. DeSteiger y, A. Gorelik z, C. Brand z. y Univ. of Melbourne, Parkville, VIC, Australia; z Melbourne Hlth., Parkville, VIC, Australia Purpose: Estimation of the lifetime risk of joint replacement surgery is an emerging field in musculoskeletal epidemiology. While global burden of disease data are valuable for understanding disease incidence and prevalence and the relative impact of a disease on patients' lives(1), lifetime risk provides an alternative method of quantifying population disease burden and associated healthcare utilisation.(2) Gaining insight into population-wide fluctuations, which may be independent of disease burden, can be useful for budget priority setting and assessing the impact of policy changes on healthcare utilisation. These data may also support advocacy activities for policy and funding changes. Our primary aim was to investigate lifetime risk of total hip (THR) and total knee (TKR) replacement surgery. As changes in the lifetime risk of joint replacement over time could be mediated by environmental, health system or patient and clinician-level factors, we also sought to describe temporal trends in incidence by relevant factors which may impact utilisation of these procedures. Methods: We analysed a population-based cohort of patients who received a primary THR or TKR in Victoria, Australia from 1999 to 2008. Hospital separations and life tables were used to estimate lifetime risk. Temporal changes in THR and TKR incidence were examined according to healthcare setting (public versus private), socio-economic status (SES) and geographic location (regional versus metropolitan). Results: We identified 45,775 patients receiving a primary THR and 43,570 receiving a primary TKR over the time period. The lifetime risk by year for each procedure for a person aged 40-49 years is reported in Figure 1 . There was a greater increase in the lifetime risk of TKR when compared to THR, particularly for females. We also identified an increasing number of both procedures in private hospitals (increase in THR of 0.14 per 1000 and TKR of 0.60 per 1000 over the time period), for people in middle socio-economic groups (increase in THR of 0.11 per 1000 and TKR of 0.07 per 1000), low socio-economic groups (increase in THR of 0.19 per 1000 and TKR of 0.10 per 1000) and in rural areas (increase in THR of 0.24 per 1000 and TKR of 0.70 per 1000) (Figure 2 ). The proportion of rural patients treated in private hospitals tended to be significantly less than patients in metropolitan settings (52.3% v 68.6% for THR and 51.3% v 65.7% for TKR, p<0.01 for both). With the exception of the increase in THRs in the middle socio-economic group, increases were more pronounced for TKRs over the time period. Conclusions: The larger increase in lifetime risk of TKR over the study period could be partly attributed to the ageing population, with more people aged over 80 receiving TKRs, increased rates of sporting injuries(3) and rising rates of obesity (all risk factors for knee OA incidence (4, 5, 6, 7) ). As the number of TKRs increased most in private hospitals, it may also relate to insurance incentives introduced at the beginning of the study period. Increases in the number of joint replacement procedures performed for patients in regional areas suggest some reductions over time in known disparities. The larger increase in incidence for patients in regional areas could relate to greater previously unmet need, a higher burden of OA in rural areas related to higher rates of obesity and manual occupations and the increased provision of orthopaedic services in rural areas over the past decade. The lifetime risk of THR performed on women was found to be similar to males, despite a higher burden of hip OA. This difference may indicate under-utilisation of surgery by females. Similarly, low SES was associated with an overall lower incidence of THR and TKR during the study period. In Australia, people with low SES generally have reduced access to the private hospital system. This finding is consistent with studies from England and Canada which have reported reduced utilisation of TKR by lower SES groups. (8-10 Purpose: Some prior research findings have suggested that females have poorer outcomes following total knee replacement (TKR) than males. Studies also have suggested that females with the same clinical profile as males are less likely to be offered hip or knee replacement. Moreover, some studies report that females have worse pain and functional status compared to males at the time of TKR. Given that presurgery status remains the strongest predictor of outcome following TKR, this study examined whether females were at risk of poorer pain and functional outcomes at 6 and 12 months following TKR independent of pre-surgery status. Methods:This study utilized data from an existing cohort of 494 people who underwent primary TKR for osteoarthritis. The primary outcomes of interest were the Pain and Function/Daily Activity subscales of the Knee Injury and Osteoarthritis Outcome Score (KOOS) (lower scores indicate worse status) at 6 and 12 months post-surgery. In addition, the patient-completed survey captured age, sex, body mass index (BMI), education level, presence of low back pain (LBP), depression, number of comorbidities, and symptomatic joint count. Descriptive statistics were calculated by sex for the personal and health status characteristics and the KOOS. A sequential series of regression analyses were conducted for each of the pain and function 
